
New groundbreaking drug-resistant TB regimen to be available next year
The new regimen involves a combination of four to five drugs taken over six months and offers a shorter, more accessible treatment option.
The new regimen involves a combination of four to five drugs taken over six months and offers a shorter, more accessible treatment option.
Mashiqana's foundation addresses healthcare discrimination, and mental health stigma, while supporting local schools and empowering volunteers to advocate for change.